Eczacıbaşı İlaç Sanayi ve Finansal Yatırımlar Sanayi ve Ticaret A.Ş.

Overview

Eczacıbaşı İlaç Sanayi ve Finansal Yatırımlar Sanayi ve Ticaret A.Ş. is a Turkish private investment firm established in 1973, specializing in a wide range of asset classes, including private equity, venture capital, real estate, infrastructure, commodities, hedge funds, fixed income, crypto, distressed and special situations, ESG and impact investing, and collectibles & art. The firm is actively involved in various stages of investment, from seed to distressed situations, and has a geographical focus spanning multiple countries, including Turkey, the United States, Germany, the United Kingdom, France, Italy, Spain, the Netherlands, Belgium, Russia, China, Japan, South Korea, India, Australia, Brazil, Mexico, South Africa, Egypt, and Saudi Arabia. The industries in which the firm invests are diverse, encompassing pharmaceuticals, consumer products, building products, healthcare, natural resources, technology, finance, real estate development, information technology, media, chemicals, automotive, energy, telecommunications, and retail. The firm typically invests between $1 million and $50 million in its portfolio companies, aiming to create value across various sectors and stages of investment. Eczacıbaşı İlaç Sanayi ve Finansal Yatırımlar Sanayi ve Ticaret A.Ş. is committed to enhancing the quality of life in the communities it serves by offering responsible products and services that respect the individual, society, and the environment. The firm's investment philosophy focuses on balancing the needs of the business world with the sustainability of natural resources, striving to shape the future of the sectors in which it operates through the embrace of digital technologies, data, and new ways of doing business. With a strong track record in various industries and investment stages, the firm continues to contribute to the growth and development of its portfolio companies and the broader economy.